General Hospital Psychiatry
Volume 32, Issue 4 , Pages 360-367 , July 2010

Guideline-concordant antidepressant use among patients with major depressive disorder

  • Shih-Yin Chen, Ph.D.

      Affiliations

    • Abt Bio-Pharma Solutions, Inc., Lexington, MA 02421, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 781 372 6516; fax: +1 781 372 6681.
    • ,
  • Richard A. Hansen, Ph.D.

      Affiliations

    • Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA
    • ,
  • Bradley N. Gaynes, M.D., M.P.H.

      Affiliations

    • Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    • ,
  • Joel F. Farley, Ph.D.

      Affiliations

    • Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA
    • ,
  • Joseph P. Morrissey, Ph.D.

      Affiliations

    • Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    • Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    • Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    • ,
  • Matthew L. Maciejewski, Ph.D.

      Affiliations

    • Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, NC 27705, USA
    • Division of General Internal Medicine, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA

Received 20 December 2009 ,Accepted 15 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Conflict of interest statement: Dr. Hansen is supported by grant KL2RR025746 from the National Center for Research Resources. A portion of this work was funded by the American Association of Colleges of Pharmacy New Investigator Program (NIP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Institutes of Health or the American Association of Colleges of Pharmacy. Dr. Chen is employed by Abt Bio-Pharma Solutions. Dr. Hansen has received consulting fees from Takeda Pharmaceuticals. Dr. Farley has received grant funding from the Pfizer Foundation and consulting fees from Takeda Pharmaceuticals. Dr. Gaynes has received grants and research support from M-3 Information, Bristol-Myers Squibb Company and Novartis, and he has served as an advisor for Bristol-Myers Squibb Company. The other authors report no competing interests.

PII: S0163-8343(10)00057-5

doi: 10.1016/j.genhosppsych.2010.03.007

General Hospital Psychiatry
Volume 32, Issue 4 , Pages 360-367 , July 2010

Article Tools

* Image Usage & Resolution